Category: Practice

Publication Review: Amin Analysis on Impella and IABP

Review of Trends, Variation and Outcomes in Impella® Use Dr. Seth Bilazarian, Abiomed’s Chief Medical Officer, provides a review of the observational analysis published in Circulation and presented at AHA 2019 by Amin, et al., comparing Impella to IABP. Dr. Bilazarian notes that the study is an observational, non-FDA audited analysis that is fundamentally flawed … Continue reading “Publication Review: Amin Analysis on Impella and IABP”

The Importance of Early Intervention of Peripartum Cardiomyopathy

Dr. Uri Elkayam discusses Impella Support for PPCM Dr. Uri Elkayam discusses the importance of recognizing and treating peripartum cardiomyopathy (PPCM). He explains that the majority of patients who require mechanical circulatory support or transplant develop deterioration of heart function to the point where they present with cardiogenic shock. Yet he emphasizes, “The potential for … Continue reading “The Importance of Early Intervention of Peripartum Cardiomyopathy”

Establishing A Heart Recovery Center

A Significant Step in Managing Cardiogenic Shock Dr. Hiram Bezerra discusses the first heart recovery center in his region, which will advance efforts to manage cardiogenic shock. Dr. Bezerra is the director of advanced coronary intervention and mechanical circulatory support at University Hospital Harrington Heart & Vascular Institute in Cleveland, Ohio. Dr. Bezerra explains that … Continue reading “Establishing A Heart Recovery Center”

High-Risk PCI with Impella 2.5

Dr. Muhammad Chaudhry of Aultman Hospital, Ohio, presents an emergent high-risk PCI case involving a 95% left main blockage along with a 80-90% blockage in the RCA and 100% distal RCA occlusion. The patient began experiencing severe chest pain and was evaluated for surgery. Shortly after, the patient went into asystole and CPR was initiated. … Continue reading “High-Risk PCI with Impella 2.5”

Managing Shock at the “Battlefront” of Surgery

Key Takeaways

  • Dr. Alexander Truesdell of the INOVA Heart and Vascular Institute discusses how physicians can apply the same shock management principles found on the battlefront into everyday surgical practice.
  • Early recognition of shock and early revascularization are two essential elements of successful treatment for shock on the battlefield as well as in conventional care centers.
For the past few decades, early revascularization has been considered the cornerstone of treatment for cardiogenic shock (CS). Despite widespread adoption and implementation of this management strategy, rates of mortality following interventional cardiology procedures for CS remain high.Dr. Alexander Truesdell of the INOVA Heart and Vascular Institute mentions in his editorial War on Shock that the method for treating CS requires a more aggressive, combat-like approach, embracing strategies he learned while serving as an interventional cardiologist in Iraq and Afghanistan.1 “Only with strong leadership, teamwork, and a national commitment to a joint integrated countrywide network of cardiogenic shock care, research, and innovation,” said Truesdell, “can we hope to achieve our desired goal of zero preventable death from cardiogenic shock.” Continue readingManaging Shock at the “Battlefront” of Surgery